Latest Breaking News On - Yongqing luo - Page 1 : vimarsana.com

Oral drug for kidney disease launched in China by Everest Medicine

Oral drug for kidney disease launched in China by Everest Medicine
outsourcing-pharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outsourcing-pharma.com Daily Mail and Mail on Sunday newspapers.

United statesZhang hongRogers yongqing luoXie jingyuanWorld congressDrug administrationUniversity first hospitalDepartment of nephrologyChina national medical products administrationShanghai jiao tong university school of medicineYongqing luoEverest medicinesBreakthrough therapy designationPeking university first hospitalOpen label extensionProfessor xie jingyuan

Everest Medicines Partner Calliditas Therapeutics Announces U S FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®

Everest Medicines Partner Calliditas Therapeutics Announces U S FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongSouth koreaRogers yongqing luoKorea ministry of foodCalliditas therapeuticsNasdaq stockholmYongqing luoChief executive officerKorea ministryDrug safetyOrphan drug designationEverest medicinesMainland chinaEverest medicineLooking statements

Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau

Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Macau special administrative regionMacau generalSouth koreaRogers yongqing luoWu kaichunAdministration bureauPharmaceutical administration bureauSpecial administrative regionNew drug applicationYongqing luoChief executive officerFirst affiliated hospitalChina taiwanEverest medicinesLooking statements

Kezar Life Sciences (KZR) and Everest Medicines Announce IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

Kezar Life Sciences (KZR) and Everest Medicines Announce IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaRogers yongqing luoChristopher kirkKezar life sciences incChina national medical products administrationEverest medicinesKezar life sciencesDrug evaluationYongqing luoChief executive officer

Everest Medicines Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis

Everest Medicines Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Wu kaichunRogers yongqing luoEuropean unionDrug administrationEuropean commissionPfizer incYongqing luoChief executive officerNew drug applicationFirst affiliated hospitalEverest medicinesLooking statements